Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Yang, Weilian ^a   Barth, Rolf F ^a   Huo, Tianyao ^a,c   Nakkula, Robin J ^a   Weldon, Michael ^a   Gupta, Nilendu ^a   Agius, Lawrence ^b   Grecula, John C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MALTA MEDICAL SCHOOL   (Malta)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Brain tumors; Carboplatin; Convection enhanced delivery; F98 glioma; Radiotherapy

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; FUROSEMIDE; MANNITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GLIOMA; LEFT HEMISPHERE; MORTALITY; NONHUMAN; OSMOTIC PUMP; PREMEDICATION; RADIATION DOSE; RAT; SURVIVAL TIME; THERMODYNAMICS; TIME OF DEATH; TISSUE PRESSURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; GLIOMA; INFUSIONS, INTRAVENTRICULAR; MALE; RADIOTHERAPY DOSAGE; RATS; RATS, INBRED F344; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84892376249     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-25     Document Type: Article

References (26)

1. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7:573-584. 10.1038/nrc2167, 17625587.
2. Stewart DJ, Molepo JM, Eapen L, Montpetit VA, Goel R, Wong PT, Popovic P, Taylor KD, Raaphorst GP. Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies. Int J Radiat Oncol Biol Phys 1994, 28:531-542. 10.1016/0360-3016(94)90082-5, 8276672.
3. Anonymous Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. EORTC Brain Tumor Group. Eur J Cancer 1991, 27:568-571. Anonymous.
4. Biston MC, Joubert A, Adam JF, Elleaume H, Bohic S, Charvet AM, Esteve F, Foray N, Balosso J. Cure of fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res 2004, 64:2317-2323. 10.1158/0008-5472.CAN-03-3600, 15059878.
5. Bobyk L, Edouard M, Deman P, Rousseau J, Adam JF, Ravanat JL, Esteve F, Balosso J, Barth RF, Elleaume H. Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma. J Exp Clin Cancer Res 2012, 31:78. 10.1186/1756-9966-31-78, 3511872, 22992374.
6. Rousseau J, Barth RF, Fernandez M, Adam JF, Balosso J, Esteve F, Elleaume H. Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. J Neurooncol 2010, 98:287-295. 10.1007/s11060-009-0074-3, 3375241, 20012464.
7. Rousseau J, Barth RF, Moeschberger ML, Elleaume H. Efficacy of intracerebral delivery of carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats. Int J Radiat Oncol Biol Phys 2009, 73:530-536. 10.1016/j.ijrobp.2008.09.018, 19147017.
8. Rousseau J, Boudou C, Barth RF, Balosso J, Esteve F, Elleaume H. Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 2007, 13:5195-5201. 10.1158/1078-0432.CCR-07-1002, 3390313, 17726137.
9. Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H. Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. J Neurooncol 2011, 101:379-390. 10.1007/s11060-010-0272-z, 20577779.
10. Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 2009, 94:299-312. 10.1007/s11060-009-9875-7, 2730996, 19381449.
11. Yang W, Barth RF, Adams DM, Ciesielski MJ, Fenstermaker RA, Shukla S, Tjarks W, Caligiuri MA. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Res 2002, 62:6552-6558.
12. Boucher Y, Salehi H, Witwer B, Harsh GR, Jain RK. Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br J Cancer 1997, 75:829-836. 10.1038/bjc.1997.148, 2063404, 9062403.
13. Madsen RWMM. Statistical Concepts 1986, Englewood Cliffs, NJ: Prentice Hall.
14. Klein JPMM. Survival Analysis Techniques for Censored and Truncated Data 2003, New York: Springer, 2.
15. Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int J Radiat Oncol Biol Phys 2000, 47:209-218. 10.1016/S0360-3016(00)00421-1, 10758326.
16. Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 2004, 58:267-277. 10.1016/S0360-3016(03)01613-4, 14697448.
17. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
18. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459-466. 10.1016/S1470-2045(09)70025-7, 19269895.
19. Rabbani A, Hinerman RW, Schmalfuss IM, Amdur RJ, Morris CG, Peters KR, Robbins KT, Mendenhall WM. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck. Am J Clin Oncol 2007, 30:283-286. 10.1097/01.coc.0000258118.38177.74, 17551306.
20. Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 2010, 12:871-881. 10.1093/neuonc/nop054, 2940677, 20511192.
21. Ferguson S, Lesniak MS. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors. Curr Drug Deliv 2007, 4:169-180. 10.2174/156720107780362302, 17456036.
22. Lopez KA, Waziri AE, Canoll PD, Bruce JN. Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res 2006, 28:542-548. 10.1179/016164106X116836, 16808887.
23. Raizer J. Issues in developing drugs for primary brain tumors: barriers and toxicities. Toxicol Pathol 2011, 39:152-157. 10.1177/0192623310391482, 21147933.
24. Mehta AI, Choi BD, Ajay D, Raghavan R, Brady M, Friedman AH, Pastan I, Bigner DD, Sampson JH. Convection enhanced delivery of macromolecules for brain tumors. Curr Drug Discov Technol 2012, 9:305-310.
25. Sampson JH, Raghavan R, Brady M, Friedman AH, Bigner D. Convection-enhanced delivery. J Neurosurg 2011, 115:463-464. discussion 465-466, 10.3171/2010.11.JNS101801, 21619413.
26. Asthagiri A, Walbridge S, Heiss J, Lonser R. Response to editorial, convection-enhanced delivery. J Neurosurg 2011, 115:467-473. 10.3171/2011.3.JNS101381, 21619409.